Postoperative cognitive dysfunction

There are 468 papers on postoperative cognitive dysfunction in aging research: 98 trials and 103 observational studies in people, 185 in animals, 69 reviews.

Disease

468 papers study it128 more mention it335 findings

12 new papers in 30 daysSee all 596 papers on postoperative cognitive dysfunction

“On the first day after surgery, there was a lot less cognitive dysfunction in the Dex group than in the controls (odds ratio [OR] = 0.25, 95% CI: 0.15~0.42, P<0.001).”
Effects of dexmedetomidine on early cognitive function in elderly patients after abdominal surgery: a meta-analysisMinerva anestesiologica2023doi:10.23736/s0375-9393.23.17399-8
  • Human trial98
  • Humans103
  • Animals185

Interventions

44

Dexmedetomidine

downin humans14no changein humans2downin mice1OR 0.26

16 studies
  1. Dexmedetomidine decreases postoperative cognitive dysfunction in humans (all doses (low, medium and high) compared with normal saline control).

    “all doses of Dex reduced the incidence of Postoperative cognitive dysfunction (POCD)”

    Human trialall doses (low, medium and high) compared with normal saline controlfemalesn = 165

    Impact of dexmedetomidine on postoperative cognitive dysfunction and inflammatory response in older adult female patients undergoing laparoscopic cholecystectomy

    Frontiers in surgery

  2. Dexmedetomidine decreases postoperative cognitive dysfunction in humans (elderly patients undergoing radical colon cancer surgery under general anesthesia).

    “a lower incidence of cognitive dysfunction on the 1st and 5th postoperative days”

    Human trialelderly patients undergoing radical colon cancer surgery under general anesthesiapostoperative days 1 and 5n = 117

    Application value of dexmedetomidine in anesthesia for elderly patients undergoing radical colon cancer surgery

    World journal of gastrointestinal surgery

  3. Dexmedetomidine showed no clear effect on postoperative cognitive dysfunction in humans (assessed at 7, 30 and 90 days postoperatively).

    “When the patients were assessed 7 days, 30 days, and 90 days postoperatively, there was no significant difference in POCD incidence among the three groups.”

    Human trialassessed at 7, 30 and 90 days postoperatively7, 30 and 90 daysn = 90

    Effects of different anesthetic regimens on postoperative cognitive function of elderly patients undergoing thoracic surgery: a double-blinded randomized controlled trial

    Journal of cardiothoracic surgery

  4. Dexmedetomidine decreases postoperative cognitive dysfunction in humans (10.0% vs. 40.0%).

    “significantly lower than that in the PS (combined anesthetization with propofol and sevoflurane) group, 1 day post-surgery (10.0% vs. 40.0%, P = 0.008)”

    Human trialadded to propofol, remifentanil and sevoflurane anesthesia, compared with propofol-sevoflurane (PS) group1 day post-surgeryn = 90

    Effects of different anesthetic regimens on postoperative cognitive function of elderly patients undergoing thoracic surgery: a double-blinded randomized controlled trial

    Journal of cardiothoracic surgery

  5. Dexmedetomidine showed no clear effect on postoperative cognitive dysfunction in humans (13.3% vs. 10.0%).

    “Patients in Group PS had a higher incidence of POCD than patients in the Group PSD at the corresponding time point (40.0% vs. 10.0%, P = 0.008); the different incidences of POCD between Group P and Group PSD showed no significant difference (13.3% vs. 10.0%; P = 0.690).”

    Human trialn = 90

    Effects of different anesthetic regimens on postoperative cognitive function of elderly patients undergoing thoracic surgery: a double-blinded randomized controlled trial

    Journal of cardiothoracic surgery

  6. Dexmedetomidine protects against postoperative cognitive dysfunction in humans (versus saline control).

    “compared to the saline group, both groups had higher MMSE and MoCA scores and decreased incidences of POCD”

    Human trialversus saline control

    Comparison of the effects of remimazolam and dexmedetomidine on early postoperative cognitive function in elderly patients with gastric cancer

    Frontiers in aging neuroscience

  7. Dexmedetomidine decreases postoperative cognitive dysfunction in humans (versus normal saline control; cataract surgery under peribulbar block) (significant decline in patients developing POCD, P < 0.0001).

    “In comparison with control group, ketamine and dexmedetomidine groups exhibited a significant decline in number of patients who developed POCD (P < 0.0001)”

    Human trialversus normal saline control; cataract surgery under peribulbar block0.5 μg/kg/h

    Effects of ketamine or dexmedetomidine on postoperative cognitive dysfunction after cataract surgery: A randomized controlled trial

    Indian journal of anaesthesia

  8. Dexmedetomidine decreases postoperative cognitive dysfunction in humans (compared with placebo).

    “Pairwise and network meta-analysis showed dexmedetomidine was significantly reducing the incidence of POCD when compared with placebo.”

    Human trialcompared with placebo

    Preventing postoperative cognitive dysfunction using anesthetic drugs in elderly patients undergoing noncardiac surgery: a systematic review and meta-analysis

    International journal of surgery (London, England)

  9. Dexmedetomidine showed no clear effect on postoperative cognitive dysfunction in humans (compared with lidocaine) (29.03% lidocaine vs 24.1% dexmedetomidine, P = 0.77).

    “There was no significant difference in the incidence of POCD”

    Human trialcompared with lidocaine

    Comparative evaluation of intraoperative dexmedetomidine versus lidocaine for reducing postoperative cognitive decline in the elderly: a prospective randomized controlled trial

    Anaesthesiology intensive therapy

  10. Dexmedetomidine showed no clear effect on postoperative cognitive dysfunction in humans (compared to lidocaine) (24.1% vs 29.03%).

    “Nine patients (29.03%) in the lidocaine group and 7 patients (24.1%) in the dexmedetomidine group showed an increase of ≥ 20% in the test scores in > 2 tests and satisfied the predetermined criteria for diagnosis of POCD on postoperative day 3.”

    Human trialcompared to lidocainepostoperative day 3n = 64

    Comparative evaluation of intraoperative dexmedetomidine versus lidocaine for reducing postoperative cognitive decline in the elderly: a prospective randomized controlled trial

    Anaesthesiology intensive therapy

All 19

More on Dexmedetomidine

Esketamine

no changein humans2downin mice2RR 0.47

4 studies
  1. Esketamine showed no clear effect on postoperative cognitive dysfunction in elderly patients undergoing thoracoscopic lobectomy (RD, −22.5%; 95% CI, −44.8% to −0.2%).

    “The overall incidence of POCD in this trial was 31.3%, including 8 (20%) patients in Group F and 17 (42.5%) patients in Group C (RD, −22.5%; 95% CI, −44.8% to −0.2%; P = 0.054).”

    Human trialin elderly patients undergoing thoracoscopic lobectomythree daysn = 80

    The Effect of Opioid-Free Anesthesia with Esketamine on Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Thoracoscopic Surgery: A Prospective, Randomized, Controlled Trial

    Drug design, development and therapy

  2. Esketamine showed no clear effect on postoperative cognitive dysfunction in humans (elderly patients undergoing thoracoscopic lung cancer surgery) (20% vs 42.5%, RR 0.47 (95% CI 0.24 to 0.92), p = 0.054).

    “Esketamine-based OFA did not significantly reduce POCD incidence”

    Human trialelderly patients undergoing thoracoscopic lung cancer surgerywithin 3 daysn = 80

    The Effect of Opioid-Free Anesthesia with Esketamine on Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Thoracoscopic Surgery: A Prospective, Randomized, Controlled Trial

    Drug design, development and therapy

  3. Esketamine showed no clear effect on postoperative cognitive dysfunction in humans.

    “The incidence of dNCR at 7 days after surgery was lower in group S, compared with patients in group C (P<0.05); however, the incidence of POCD 3 months after surgery was similar in both groups (P>0.05).”

    Human trial5min before the beginning of the surgeryn = 67

    Effect of Subanesthetic Dose of Esketamine on Perioperative Neurocognitive Disorders in Elderly Undergoing Gastrointestinal Surgery: A Randomized Controlled Trial

    Drug design, development and therapy

  4. Esketamine showed no clear effect on postoperative cognitive dysfunction in humans (undergoing gastrointestinal surgery under general anesthesia) (6.06% vs 14.37% P=0.247).

    “there was no difference in both groups regarding POCD 3 months postoperatively (6.06% vs 14.37% P=0.247).”

    Human trialundergoing gastrointestinal surgery under general anesthesiaintravenous0.15 mg/kg3 months postoperativelyn = 84

    Effect of Subanesthetic Dose of Esketamine on Perioperative Neurocognitive Disorders in Elderly Undergoing Gastrointestinal Surgery: A Randomized Controlled Trial

    Drug design, development and therapy

  5. Esketamine decreases postoperative cognitive dysfunction in mice after exploratory laparotomy under isoflurane anesthesia.

    “intraperitoneal administration of esketamine could alleviate POCD, as demonstrated through a suite of behavioral tests.”

    Animalsafter exploratory laparotomy under isoflurane anesthesia10 mg/kg

    Esketamine Alleviates Postoperative Cognitive Dysfunction via Rock2/Add1 Signaling Pathway in Aged Mice

    Neurochemical research

  6. Esketamine protects against postoperative cognitive dysfunction in mice (aged POCD mouse model).

    “Our findings showed that esketamine effectively mitigated POCD in aged mice.”

    Animalsaged POCD mouse model

    Role and mechanism of esketamine in improving postoperative cognitive dysfunction in aged mice through the TLR4/MyD88/p38 MAPK pathway

    The Kaohsiung journal of medical sciences

More on Esketamine

Ulinastatin

downin humans4OR 0.28

4 studies
  1. Ulinastatin prevents postoperative cognitive dysfunction in humans (compared with dexmedetomidine) (OR = 0.28, 95% CI 0.10 to 0.71).

    “ulinastatin may be more effective in preventing POCD than dexmedetomidine [odds ratio (OR) = 0.28, 95% confidence interval (CI) = (0.10, 0.71)]”

    Human trialcompared with dexmedetomidine

    Effects of anesthetic adjunctive agents on postoperative cognitive dysfunction in elderly patients undergoing noncardiac surgery: A Bayesian network meta-analysis

    Brain and behavior

  2. Ulinastatin decreases postoperative cognitive dysfunction in humans (elderly patients undergoing spinal surgery; total intravenous anesthesia) (16% vs. 43%, χ2 = 5.079, P = 0.024).

    “Ulinastatin infusion significantly reduced the incidence of POCD in elderly patients undergoing spine surgery”

    Human trialelderly patients undergoing spinal surgery; total intravenous anesthesia10,000 units/kg then 5000 units/kg

    Ulinastatin May Significantly Improve Postoperative Cognitive Function of Elderly Patients Undergoing Spinal Surgery by Reducing the Translocation of Lipopolysaccharide and Systemic Inflammation

    Frontiers in pharmacology

  3. Ulinastatin decreases postoperative cognitive dysfunction in humans after one-lung ventilation surgery with neoadjuvant chemotherapy (23.7% vs 45.9% incidence).

    “The U group had a lower incidence of POCD than C group (23.7 % versus 45.9 %, P = 0.043).”

    Human trialafter one-lung ventilation surgery with neoadjuvant chemotherapy10,000 U/kg before anesthesia, then 5000 U/kg dailypostoperative days 1 to 3n = 80

    Effects of ulinastatin on early postoperative cognitive function after one-lung ventilation surgery in elderly patients receiving neoadjuvant chemotherapy

    Metabolic brain disease

  4. Ulinastatin prevents postoperative cognitive dysfunction in humans (perioperative use in elderly patients under general anesthesia).

    “effectively prevent the occurrence of POCD and reduce its incidence”

    Reviewperioperative use in elderly patients under general anesthesia

    Efficacy and safety of ulinastatin on cognitive dysfunction after general anesthesia in elderly patients: A protocol for systematic review and meta-analysis

    Medicine

More on Ulinastatin

Parecoxib

downin humans2no changein humans1

2 studies
  1. Parecoxib showed no clear effect on postoperative cognitive dysfunction in humans (at 3-month follow-up after total knee arthroplasty) (9.7% vs 6.7%).

    “no significant difference was found between groups C and P at 3-month follow-up (9.7% vs 6.7%)”

    Human trialat 3-month follow-up after total knee arthroplastyparecoxib sodium3 months

    Parecoxib prevents early postoperative cognitive dysfunction in elderly patients undergoing total knee arthroplasty: A double-blind, randomized clinical consort study

    Medicine

  2. Parecoxib decreases postoperative cognitive dysfunction in humans (at 1 week after total knee arthroplasty) (16.7% vs 33.9%).

    “POCD incidence in group P was significantly lower compared with that of group C at 1 week after surgery (16.7% vs 33.9%; P < 0.05)”

    Human trialat 1 week after total knee arthroplastyparecoxib sodium1 week

    Parecoxib prevents early postoperative cognitive dysfunction in elderly patients undergoing total knee arthroplasty: A double-blind, randomized clinical consort study

    Medicine

  3. Parecoxib decreases postoperative cognitive dysfunction in humans (perioperative use compared with control).

    “perioperative intravenous parecoxib could remarkably reduce the incidence of POCD”

    Reviewperioperative use compared with controln = 1,106

    Intravenous parecoxib for early postoperative cognitive dysfunction in elderly patients: evidence from a meta-analysis

    Expert review of clinical pharmacology

More on Parecoxib

Propofol

downin humans1no changein humans1

2 studies
  1. Propofol showed no clear effect on postoperative cognitive dysfunction in humans (compared with dexmedetomidine and midazolam sedation; assessed 1 year after surgery) (14.0%, 10.6% and 14.9% across the three groups).

    “the incidence of POCD was not significantly different among the 3 groups (14.0%, 10.6% vs. 14.9%, χ = 0.016 and 0.382, P = 0.899 and 0.536)”

    Human trialcompared with dexmedetomidine and midazolam sedation; assessed 1 year after surgery1 year

    Effects of propofol, dexmedetomidine, and midazolam on postoperative cognitive dysfunction in elderly patients: a randomized controlled preliminary trial

    Chinese medical journal

  2. Propofol decreases postoperative cognitive dysfunction in humans (compared with inhaled anesthetic agents).

    “The most evident finding was that propofol attenuated POCD compared to inhaled anesthetic agents.”

    Reviewcompared with inhaled anesthetic agents

    Impact of Ketamine and Propofol on Cognitive Function in Elderly Patients: A Systematic Review

    Cureus

More on Propofol

Ketamine

downin humans2

2 studies
  1. Ketamine prevents postoperative cognitive dysfunction in humans (efficiency ranking in the network meta-analysis).

    “The efficiency ranking results also find that ulinastatin and ketamine might provide better effects regarding POCD prevention.”

    Human trialefficiency ranking in the network meta-analysis

    Effects of anesthetic adjunctive agents on postoperative cognitive dysfunction in elderly patients undergoing noncardiac surgery: A Bayesian network meta-analysis

    Brain and behavior

  2. Ketamine decreases postoperative cognitive dysfunction in humans (versus normal saline control; cataract surgery under peribulbar block) (significant decline in patients developing POCD, P < 0.0001).

    “In comparison with control group, ketamine and dexmedetomidine groups exhibited a significant decline in number of patients who developed POCD (P < 0.0001)”

    Human trialversus normal saline control; cataract surgery under peribulbar block0.3 mg/kg/h

    Effects of ketamine or dexmedetomidine on postoperative cognitive dysfunction after cataract surgery: A randomized controlled trial

    Indian journal of anaesthesia

More on Ketamine

High-fat diet

upin mice2

2 studies
  1. High-fat diet increases postoperative cognitive dysfunction in mice after isoflurane exposure and tibial fracture surgery.

    “An HFD exacerbates POCD in older mice.”

    Animalsafter isoflurane exposure and tibial fracture surgerymales

    Obesity caused by a high-fat diet regulates the Sirt1/PGC-1α/FNDC5/BDNF pathway to exacerbate isoflurane-induced postoperative cognitive dysfunction in older mice

    Nutritional neuroscience

  2. High-fat diet increases postoperative cognitive dysfunction in mice with sevoflurane anesthesia and exploratory surgery.

    “HFD can aggravate POCD in aged C57BL/6 mice”

    Animalswith sevoflurane anesthesia and exploratory surgery8 weeksmales

    High-fat diet aggravates postoperative cognitive dysfunction in aged mice

    BMC anesthesiology

More on High-fat diet

Multidomain intervention

no changein humans1

1 study
  1. Multidomain intervention showed no clear effect on postoperative cognitive dysfunction in humans (8.0% vs 24.0%).

    “The incidence of POCD in the control group (24.0%) was relatively higher in the control group than that in the experimental group (8.0%), but there was no significant difference between the two groups.”

    Human trial14 days after the operationn = 50

    Clinical Effect of Application of Interventional Treatment Models for Improvement of Quality of Postoperative Recovery in Elderly Patients with Total Hip Arthroplasty

    International journal of general medicine

  2. Multidomain intervention showed no clear effect on postoperative cognitive dysfunction in humans after total hip arthroplasty (without statistical significance).

    “The incidence of POCD in the experimental group was lower and its duration was shorter than in the control group but without statistical significance.”

    Human trialafter total hip arthroplastyn = 50

    Clinical Effect of Application of Interventional Treatment Models for Improvement of Quality of Postoperative Recovery in Elderly Patients with Total Hip Arthroplasty

    International journal of general medicine

More on Multidomain intervention

Epidural anesthesia

downin humans1

1 study
  1. Epidural anesthesia decreases postoperative cognitive dysfunction in humans (combined with general anesthesia versus general anesthesia alone in liver cancer surgery) (P < 0.05).

    “There was no significant difference in the score between the two groups before operation and 3 days and 7 days after operation (P > 0.05), while the score was significantly better in the joint group than that in the GA group at 6 hours and 1 day after operation (P < 0.05).”

    Human trialcombined with general anesthesia versus general anesthesia alone in liver cancer surgery

    Effects of Combined Epidural Anesthesia and General Anesthesia on Cognitive Function and Stress Responses of Elderly Patients Undergoing Liver Cancer Surgery

    Journal of oncology

  2. Epidural anesthesia decreases postoperative cognitive dysfunction in humans (undergoing liver cancer surgery).

    “combined epidural anesthesia and general anesthesia can significantly reduce postoperative cognitive dysfunction and inhibit postoperative stress responses in elderly patients undergoing liver cancer surgery.”

    Human trialundergoing liver cancer surgeryn = 115

    Effects of Combined Epidural Anesthesia and General Anesthesia on Cognitive Function and Stress Responses of Elderly Patients Undergoing Liver Cancer Surgery

    Journal of oncology

More on Epidural anesthesia

Methoxamine

no changein humans1upin humans1

1 study
  1. Methoxamine showed no clear effect on postoperative cognitive dysfunction in humans (2–3 μg·kg−1·min−1 during epidural anesthesia) (M1 6.7% and M2 6.7% vs control 5.3%).

    “Intravenous infusion of methoxamine at 2-3 μg·kg−1·min−1 can maintain stable hemodynamics in elderly patients during epidural anesthesia for hip-joint replacement surgery, without increasing the incidence of POCD.”

    Human trial2–3 μg·kg−1·min−1 during epidural anesthesia2–3 μg·kg−1·min−1during surgeryn = 300

    Dose-dependent effects of intravenous methoxamine infusion during hip-joint replacement surgery on postoperative cognitive dysfunction and blood TNF-α level in elderly patients: a randomized controlled trial

    BMC anesthesiology

  2. Methoxamine increases postoperative cognitive dysfunction in humans (4 μg·kg−1·min−1 (M3 group) versus control) (18.7% vs 5.3% control incidence).

    “the incidence of POCD, which was higher in the M3 group (18.7%) than in the control group (5.3%)”

    Human trial4 μg·kg−1·min−1 (M3 group) versus control4 μg·kg−1·min−1during surgeryn = 300

    Dose-dependent effects of intravenous methoxamine infusion during hip-joint replacement surgery on postoperative cognitive dysfunction and blood TNF-α level in elderly patients: a randomized controlled trial

    BMC anesthesiology

More on Methoxamine

Etomidate

downin humans1

1 study
  1. Etomidate decreases postoperative cognitive dysfunction in humans (8.3% POCD rate on day 1 in the medium-dose group).

    “Etomidate 0.2 mg/kg with nerve block achieves favorable hemodynamics and minimizes POCD and adverse reactions in elderly hernia surgery”

    Human trialhernia surgery with nerve block, sufentanil, and remimazolam; compared with low- and high-dose etomidate0.2 mg/kgpostoperative day 1n = 36

    Optimal Etomidate Induction Dosage Combined With Nerve Block Minimizes Postoperative Cognitive Dysfunction and Enhances Hemodynamic Stability in Elderly Hernia Patients

    The Annals of pharmacotherapy

More on Etomidate

Electroacupuncture + dexmedetomidine

downin humans1

1 study
  1. Electroacupuncture + dexmedetomidine decreases postoperative cognitive dysfunction in humans (at 1 month after hip or knee arthroplasty) (10% vs 30% (EA group) and 32.5% (Dex group)).

    “The incidence of POCD was significantly lower in the EA+Dex group (10%) compared with the EA group (30%) and the Dex group (32.5%) (p < 0.05).”

    Human trialat 1 month after hip or knee arthroplasty1 month

    Effect of Electroacupuncture Combined with Dexmedetomidine on Postoperative Cognitive Dysfunction in Hip and Knee Arthroplasty Patients

    Complementary medicine research

More on Electroacupuncture + dexmedetomidine

Multimodal prehabilitation

no changein humans1OR 1.37

1 study
  1. Multimodal prehabilitation showed no clear effect on postoperative cognitive dysfunction in humans (cardiac surgery) (OR 1.37, 95% CI 0.54-3.50, P = 0.52).

    “a 4-6-week multimodal prehabilitation program did not reduce postoperative cognitive dysfunction 3 months after cardiac surgery”

    Human trialcardiac surgery4-6 weeksn = 116

    Impact of a multimodal prehabilitation program on postoperative cognitive dysfunction: a single-center randomized controlled trial

    Journal of clinical anesthesia

More on Multimodal prehabilitation

Transcutaneous auricular vagus nerve stimulation

downin humans1

1 study
  1. Transcutaneous auricular vagus nerve stimulation decreases postoperative cognitive dysfunction in humans (compared with sham stimulation) (10.2% vs 32.7%; χ2 = 7.498, p = 0.006).

    “The incidence of POCD in the taVNS group was significantly lower than that in the sham group (10.2% vs 32.7%, χ2 = 7.498, p = 0.006).”

    Human trialcompared with sham stimulationto postoperative day 7n = 103

    Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Postoperative Cognitive Dysfunction in Older Patients: A Randomized Controlled Clinical Trial

    Neuromodulation : journal of the International Neuromodulation Society

More on Transcutaneous auricular vagus nerve stimulation

Ambient temperature

no changein humans1

1 study
  1. Ambient temperature showed no clear effect on postoperative cognitive dysfunction in humans (elderly patients undergoing laparoscopic surgery).

    “There were no significant differences in the incidence of POCD on postoperative days 1, 3, and 7 between patients undergoing laparoscopic surgery in winter vs summer.”

    Human trialelderly patients undergoing laparoscopic surgery

    Impact of ambient temperature on postoperative cognitive dysfunction in elderly patients surgery: A seasonal comparison in tropical regions

    World journal of psychiatry

More on Ambient temperature

All 44

Effects

5

Length of hospital stay

upin humans1

1 study
  1. Postoperative cognitive dysfunction increases length of hospital stay in humans (postcardiac surgery, <30 days postsurgery) (MD 1.37 days (95% CI: 0.35, 2.39)).

    “Patients who developed POCD <30 days postcardiac and noncardiac surgeries experienced longer LOS than those who did not [mean difference (MD) = 1.37 days (95% CI: 0.35, 2.39); I2 = 92.38%”

    Reviewpostcardiac surgery, <30 days postsurgery

    Outcomes associated with postoperative cognitive dysfunction: a systematic review and meta-analysis

    Age and ageing

Hospital costs

upin humans1

1 study
  1. Postoperative cognitive dysfunction is linked with higher hospital costs in humans after surgery (8973.43 USD vs. 5913.62 USD, P < 0.001).

    “incur higher hospital costs (8973.43 USD [3481.69, 11 763.74] vs. 5913.62 USD [332.43, 19 567.33]; P < 0.001)”

    Humansafter surgery1 weekn = 289

    Postoperative cognitive dysfunction in older surgical patients associated with increased healthcare utilization: a prospective study from an upper-middle-income country

    BMC geriatrics

Length of stay

upin humans1

1 study
  1. Postoperative cognitive dysfunction is linked with higher length of stay in humans after surgery (11 days vs. 8 days, P = 0.01).

    “patients with POCD were more likely to need a prolonged LOS (11 days [1, 46] vs. 8 days [2, 42]; P = 0.01)”

    Humansafter surgery1 weekn = 289

    Postoperative cognitive dysfunction in older surgical patients associated with increased healthcare utilization: a prospective study from an upper-middle-income country

    BMC geriatrics

Functional decline

no changein humans1

1 study
  1. Postoperative cognitive dysfunction was not clearly linked with functional decline in humans after surgery.

    “At their 3-month follow-ups, the patients with POCD were not associated with IADL decline.”

    Humansafter surgery3 monthsn = 289

    Postoperative cognitive dysfunction in older surgical patients associated with increased healthcare utilization: a prospective study from an upper-middle-income country

    BMC geriatrics

Mortality

upin humans1

1 study
  1. Postoperative cognitive dysfunction increases mortality in humans.

    “POD can lead to postoperative cognitive dysfunction (POCD), a more prolonged cognitive impairment associated with longer length of hospital stay and cost, premature withdrawal from the workforce, and greater 1-year mortality.”

    Review1-year

    Mind Over Matter? The Hidden Epidemic of Cognitive Dysfunction in the Older Surgical Patient

    Annals of surgery

Upstream

15

Inflammation

no changein humans1mediatesin humans1

2 studies
  1. Inflammation was not clearly linked with postoperative cognitive dysfunction in older cancer patients undergoing surgery.

    “no significant associations were shown between the early surgery-induced inflammatory response and either POCD or decline within the different cognitive domains”

    Humansin older cancer patients undergoing surgeryn = 248

    The link between the early surgery-induced inflammatory response and postoperative cognitive dysfunction in older patients

    Journal of the American Geriatrics Society

  2. Inflammation mediates postoperative cognitive dysfunction in humans.

    “Mounting evidence have shown that neuroinflammation plays an essential role in POCD.”

    Review

    Postoperative cognitive dysfunction in the aged: the collision of neuroinflammaging with perioperative neuroinflammation

    Inflammopharmacology

More on Inflammation

SIRT1

downin mice1mediatesin mice1

2 studies
  1. SIRT1 protects against postoperative cognitive dysfunction in mice (shown by SIRT1 rescue with resveratrol after splenectomy).

    “rescue of hippocampal SIRT1 expression ameliorated the cognitive impairment in the elderly mice under splenectomy”

    Animalsshown by SIRT1 rescue with resveratrol after splenectomyhippocampusmales

    Surgery-induced downregulation of hippocampal sirtuin-1 contributes to cognitive dysfunction by inhibiting autophagy and activating apoptosis in aged mice

    American journal of translational research

  2. SIRT1 mediates postoperative cognitive dysfunction in mice (cardiac surgery-induced POCD, via TLR4/NF-κB pathway).

    “SIRT1 mediates the improvement of cardiac surgery-induced postoperative cognitive dysfunction via the TLR4/NF-κB pathway.”

    Animalscardiac surgery-induced POCD, via TLR4/NF-κB pathway

    SIRT1 mediates improvement of cardiac surgery-induced postoperative cognitive dysfunction via the TLR4/NF-κB pathway

    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry

More on SIRT1

PRKCD

upin rats1

1 study
  1. PRKCD increases postoperative cognitive dysfunction in rats after SEV exposure; shown by knockdown.

    “PRKCD enhanced SEV-induced POCD in aged rats via the regulation of PINK1/PRKN mitophagy pathway”

    Animalsafter SEV exposure; shown by knockdown

    PRKCD Orchestrates Sevoflurane-Induced Cognitive Dysfunction in Aged Rats by Regulating PINK1/PRKN Mitophagy Pathway

    Journal of cellular and molecular medicine

More on PRKCD

AMPK-SIRT1 pathway

downin mice1

1 study
  1. AMPK-SIRT1 pathway protects against postoperative cognitive dysfunction in mice (POCD induced by open tibial fracture surgery under isoflurane anesthesia).

    “The AMPK/SIRT1 pathway activation mitigated POCD.”

    AnimalsPOCD induced by open tibial fracture surgery under isoflurane anesthesia

    Mechanism of the AMPK/SIRT1 pathway in gut dysbiosis-mediated postoperative cognitive dysfunction in aged mice

    The international journal of neuropsychopharmacology

Stable shift in microglial identity

mediatesin reviews1

1 study
  1. stable shift in microglial identity mediates postoperative cognitive dysfunction.

    “POCD is driven not by ongoing inflammation, but by a stable shift in microglial identity.”

    Review

    Is postoperative cognitive dysfunction a disease of microglial inflammatory memory? A state-transition model from metabolic stress to epigenetic lock-in

    Frontiers in molecular neuroscience

Sarcopenia

no changein humans1OR 1.07

1 study
  1. Sarcopenia was not clearly linked with postoperative cognitive dysfunction in humans (undergoing non-cardiac surgery under general anaesthesia) (OR 1.070, 95% CI 0.442–2.589).

    “POCD (OR: 1.070, 95% CI: 0.442, 2.589, P = 0.880) than non-sarcopenic patients.”

    Humansundergoing non-cardiac surgery under general anaesthesian = 117

    Association between preoperative frailty and postoperative delirium and cognitive dysfunction in elderly patients undergoing surgery under general anaesthesia: A prospective observational study

    Indian journal of anaesthesia

More on Sarcopenia

NLRP3

upin rats1

1 study
  1. NLRP3 increases postoperative cognitive dysfunction in rats after orthopedic surgery (tibial fracture model).

    “NLRP3 activation contributes to POCD development because it is intrinsically involved in mitochondrial dysfunction and oxidative stress after orthopedic surgery in aged rats”

    Animalsafter orthopedic surgery (tibial fracture model)males

    Oxidative stress and mitochondrial dysfunction contributes to postoperative cognitive dysfunction in elderly rats dependent on NLRP3 activation

    Metabolic brain disease

More on NLRP3

HDAC6

upin mice1

1 study
  1. HDAC6 increases postoperative cognitive dysfunction in mice (hippocampal, via NLRP3-induced microglial pyroptosis and HSP90/HSP70).

    “Our findings suggest that hippocampal HDAC6 promotes POCD by regulating NLRP3-induced microglia pyroptosis via HSP90/HSP70 in aged mice.”

    Animalshippocampal, via NLRP3-induced microglial pyroptosis and HSP90/HSP70hippocampus

    Hippocampal HDAC6 promotes POCD by regulating NLRP3-induced microglia pyroptosis via HSP90/HSP70 in aged mice

    Biochimica et biophysica acta. Molecular basis of disease

More on HDAC6

Apoptosis

mediatesin mice1

1 study
  1. Apoptosis mediates postoperative cognitive dysfunction in mice (induced by sevoflurane).

    “POCD induced by sevoflurane results from ER stress and neuroapoptosis in the hippocampus of aged mice”

    Animalsinduced by sevofluranehippocampus

    The role of PERK-eIF2α-ATF4-CHOP pathway in sevoflurane induced neuroapoptosis and cognitive dysfunction in aged mice

    Cellular signalling

More on Apoptosis

ER unfolded protein response

mediatesin mice1

1 study
  1. ER unfolded protein response mediates postoperative cognitive dysfunction in mice (induced by sevoflurane).

    “POCD induced by sevoflurane results from ER stress and neuroapoptosis in the hippocampus of aged mice”

    Animalsinduced by sevofluranehippocampus

    The role of PERK-eIF2α-ATF4-CHOP pathway in sevoflurane induced neuroapoptosis and cognitive dysfunction in aged mice

    Cellular signalling

More on ER unfolded protein response

Cytokines

no changein humans1

1 study
  1. Cytokines showed no clear effect on postoperative cognitive dysfunction in humans.

    “No correlation was found between POCD and cytokine levels.”

    Human trial

    Effect of remifentanil and fentanyl on postoperative cognitive function and cytokines level in elderly patients undergoing major abdominal surgery

    Journal of clinical anesthesia

More on Cytokines

All 15

Associations

158

Dexmedetomidine

downin humans14mixedin humans1downin reviews1RR 0.47–0.49

15 studies
  1. Dexmedetomidine lowers the risk of postoperative cognitive dysfunction in humans (postoperative following major abdominal surgery) (12.5% vs 37.5%).

    “The incidence of significant cognitive decline (>5-point fall) was lowest in D1 and D2 (12.5% each) and highest in the placebo group (37.5%, p = 0.048).”

    Human trialpostoperative following major abdominal surgery24 hoursn = 72

    The Effect of Two Different Intraoperative Doses of Dexmedetomidine on Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Major Abdominal Surgery Under General Anesthesia: A Randomized Controlled Study

    Cureus

  2. Dexmedetomidine lowers the risk of postoperative cognitive dysfunction in humans.

    “The incidence of POCD in the DEX group was lower than that in the control group, with a statistically difference.”

    Human trialn = 90

    Integrated analysis of metabolomics combined and net-work pharmacology reveals the effects of dexmedetomidine on early postoperative cognitive dysfunction in elderly patients: randomized controlled trial

    BMC anesthesiology

  3. Dexmedetomidine lowers the risk of postoperative cognitive dysfunction in humans (low, medium, and high doses).

    “Upon comparing the incidence of POCD was compared between the Dex and saline treatment groups, it was found that the low, medium, and high doses of Dex [0.4, 0.6 and 0.8 μg/(kg·h) Dex, respectively] all effectively the incidence of POCD (P < 0.05).”

    Human triallow, medium, and high doses15 min prior to anesthesia induction, followed by postoperative infusions of 0.4, 0.6, and 0.8 μg/(kg·h) Dex to maintain anesthesiafemalesn = 165

    Impact of dexmedetomidine on postoperative cognitive dysfunction and inflammatory response in older adult female patients undergoing laparoscopic cholecystectomy

    Frontiers in surgery

  4. Dexmedetomidine lowers the risk of postoperative cognitive dysfunction in humans (postoperative day 1: 11.86% vs 27.59%; day 5: 5.08% vs 18.97%).

    “On postoperative days 1 and 5, the incidence of cognitive dysfunction in group A was 11.86% and 5.08%, respectively, while those in group B were 27.59% and 18.97%, respectively; there were significant differences between the two groups (P < 0.05; Table ).”

    Human trialn = 117

    Application value of dexmedetomidine in anesthesia for elderly patients undergoing radical colon cancer surgery

    World journal of gastrointestinal surgery

  5. Dexmedetomidine lowers the risk of postoperative cognitive dysfunction in humans (40.0% vs. 10.0%).

    “Patients in Group PS had a higher incidence of POCD than patients in the Group PSD at the corresponding time point (40.0% vs. 10.0%, P = 0.008); the different incidences of POCD between Group P and Group PSD showed no significant difference (13.3% vs. 10.0%; P = 0.690).”

    Human trialn = 90

    Effects of different anesthetic regimens on postoperative cognitive function of elderly patients undergoing thoracic surgery: a double-blinded randomized controlled trial

    Journal of cardiothoracic surgery

  6. Dexmedetomidine lowers the risk of postoperative cognitive dysfunction in humans (OR 0.25 (95% CI 0.15–0.42)).

    “On the first day after surgery, there was a lot less cognitive dysfunction in the Dex group than in the controls (odds ratio [OR] = 0.25, 95% CI: 0.15~0.42, P<0.001).”

    Human trialintraoperative administration, compared with normal saline control; first day after surgeryn = 675

    Effects of dexmedetomidine on early cognitive function in elderly patients after abdominal surgery: a meta-analysis

    Minerva anestesiologica

  7. Dexmedetomidine lowers the risk of postoperative cognitive dysfunction in humans.

    “At 3 days postoperative (T6) and 7 days postoperative (T7), there was no statistically significant difference (p > 0.05) in the incidence of POCD between groups R and D, even though both were lower than the incidence of POCD in group C, which was statistically significant (p < 0.05).”

    Human trial

    Comparison of the effects of remimazolam and dexmedetomidine on early postoperative cognitive function in elderly patients with gastric cancer

    Frontiers in aging neuroscience

  8. Dexmedetomidine lowers the risk of postoperative cognitive dysfunction in humans.

    “and the incidence of POCD was lower in the DEX group.”

    Human trialn = 82

    Effect of dexmedetomidine on postoperative cognitive dysfunction and the T helper 17/regulatory T cell balance in geriatric patients undergoing orthopedic surgery: a randomized controlled study

    American journal of translational research

  9. Dexmedetomidine lowers the risk of postoperative cognitive dysfunction in humans.

    “Additionally, there was a rise in the number of patients who developed POCD in the control group when compared to ketamine and dexmedetomidine groups (P < 0.0001); however, the ketamine and dexmedetomidine groups did not vary from one another (P = 0.747)..”

    Human trialstarted 10 min before the start of surgery and continued throughout the duration of surgeryn = 90

    Effects of ketamine or dexmedetomidine on postoperative cognitive dysfunction after cataract surgery: A randomized controlled trial

    Indian journal of anaesthesia

  10. Dexmedetomidine lowers the risk of postoperative cognitive dysfunction in humans (medium- and high-dose groups compared with saline control) (significantly lower than control group (P < 0.05)).

    “The incidences of POCD in medium- and high-dose DEX groups were comparable but significantly lower than that in the control group (P < 0.05).”

    Human trialmedium- and high-dose groups compared with saline controlmedium and high maintenance doses

    Effects of dexmedetomidine doses on postoperative cognitive dysfunction and serum β- amyloid and cytokine levels in elderly patients after spine surgery: a randomized controlled trial

    Nan fang yi ke da xue xue bao = Journal of Southern Medical University

All 16

More on Dexmedetomidine

Transcutaneous electrical acupoint stimulation

downin humans6RR 0.55

6 studies
  1. Transcutaneous electrical acupoint stimulation lowers the risk of postoperative cognitive dysfunction in humans.

    “The POCD incidence in the TEAS group was significantly lower than that in the control group (P = 0.028).”

    Human trialn = 40

    Effects of conventional nursing in the operating room combined with transcutaneous electrical acupoint stimulation on postoperative cognitive dysfunction after total knee arthroplasty in elderly patients

    Journal of orthopaedic surgery and research

  2. Transcutaneous electrical acupoint stimulation lowers the risk of postoperative cognitive dysfunction in humans (postoperative total knee arthroplasty) (10% vs 40%).

    “The incidence of POCD in the TEAS group was 10%, lower than in the control group (40%) (P < 0.05).”

    Human trialpostoperative total knee arthroplastyn = 40

    Effects of conventional nursing in the operating room combined with transcutaneous electrical acupoint stimulation on postoperative cognitive dysfunction after total knee arthroplasty in elderly patients

    Journal of orthopaedic surgery and research

  3. Transcutaneous electrical acupoint stimulation lowers the risk of postoperative cognitive dysfunction in humans (20% vs 65.4% on day 1, 7.3% vs 43.6% on day 7, and 3.6% vs 40% on day 30).

    “Following the study procedure, the incidence of POCD in the sham-TEAS group was always significantly higher than in the TEAS group (postoperative day 1: 65.4% vs 20%, postoperative day 7: 43.6% vs 7.3%, and postoperative day 30: 40% vs 3.6%, all P < 0.001).”

    Human trialfrom 30 min before anesthesia induction until the end of the surgeryn = 110

    Effect of transcutaneous electrical acupoint stimulation on postoperative cognitive function in older patients with lung cancer: A randomized, double-blind, placebo-controlled trial

    Heliyon

  4. Transcutaneous electrical acupoint stimulation lowers the risk of postoperative cognitive dysfunction in humans after thoracoscopic pulmonary resection for lung cancer (20% vs 65.4% at day 1, 7.3% vs 43.6% at day 7, 3.6% vs 40% at day 30, all P < 0.001).

    “the incidence of POCD in the sham-TEAS group was always significantly higher than in the TEAS group (65.4% vs 20%, 43.6% vs 7.3%, 40% vs 3.6%, all P < 0.001).”

    Human trialafter thoracoscopic pulmonary resection for lung cancern = 128

    Effect of transcutaneous electrical acupoint stimulation on postoperative cognitive function in older patients with lung cancer: A randomized, double-blind, placebo-controlled trial

    Heliyon

  5. Transcutaneous electrical acupoint stimulation lowers the risk of postoperative cognitive dysfunction in humans (22% and 18.4% vs 43.7%).

    “On the 3rd day after the operation, POCD occurred in 11 (22%), 9 (18.4%) and 21 (43.7%) patients in groups A, B, and C, respectively, and there was no significant difference between groups A and B (P = 0.616).”

    Human trialup to 7 days after the surgeryn = 147

    Transcutaneous electrical acupoint stimulation for reducing cognitive dysfunction in lumbar spine surgery: A randomized, controlled trail

    Frontiers in aging neuroscience

  6. Transcutaneous electrical acupoint stimulation lowers the risk of postoperative cognitive dysfunction in older patients with lumbar spine surgery (18.3% or 22.4% vs 42.9%).

    “Perioperative TEAS intervention could reduce the level of inflammatory factors IL-6, TNF-α in the blood of older patients with lumbar spine surgery, and reduce the incidence of POCD.”

    Human trialin older patients with lumbar spine surgery

    Transcutaneous electrical acupoint stimulation for reducing cognitive dysfunction in lumbar spine surgery: A randomized, controlled trail

    Frontiers in aging neuroscience

  7. Transcutaneous electrical acupoint stimulation lowers the risk of postoperative cognitive dysfunction in humans (gastrointestinal tumor surgery under general anesthesia) (21.88% vs 40.63%).

    “The incidence of POCD in the TEAS group (21.88%) was lower than those in the sham TEAS group (40.63%).”

    Human trialgastrointestinal tumor surgery under general anesthesia

    Transcutaneous electrical acupoint stimulation for postoperative cognitive dysfunction in geriatric patients with gastrointestinal tumor: a randomized controlled trial

    Trials

  8. Transcutaneous electrical acupoint stimulation lowers the risk of postoperative cognitive dysfunction in humans (hip replacement surgery) (RR: 0.55, 95% CI: 0.41, 0.73, P<0.001).

    “along with a lower postoperative cognitive dysfunction rate (RR: 0.55, 95% CI: 0.41, 0.73, P<0.001).”

    Reviewhip replacement surgery

    Evaluation of transcutaneous electrical acupoint stimulation for improving pain and cognitive function in elderly patients around the perioperative period of hip replacement surgery: A meta-analysis

    PloS one

  9. Transcutaneous electrical acupoint stimulation lowers the risk of postoperative cognitive dysfunction in humans after general anesthesia (p<0.00001).

    “TEAS reduced POCD incidence on the 1st and 3rd but not on the 5th and 7th postoperative days (p<0.00001; p<0.00001; p = 0.20; p = 0.30).”

    Reviewafter general anesthesia1st and 3rd postoperative days

    Transcutaneous electrical acupoint stimulation affects older adults' cognition after general anesthesia: A meta-analysis

    Geriatric nursing (New York, N.Y.)

More on Transcutaneous electrical acupoint stimulation

Propofol

downin humans3upin humans1RR 0.37

4 studies
  1. Propofol lowers the risk of postoperative cognitive dysfunction in humans (compared with dexmedetomidine and midazolam sedation; assessed 7 days after surgery) (18.2% vs 40.0% (dexmedetomidine) and 51.9% (midazolam)).

    “POCD incidence in propofol group was significantly lower than that in dexmedetomidine and midazolam groups (18.2% vs. 40.0%, 51.9%, χ = 6.342 and 13.603, P = 0.012 and < 0.001)”

    Human trialcompared with dexmedetomidine and midazolam sedation; assessed 7 days after surgery7 days

    Effects of propofol, dexmedetomidine, and midazolam on postoperative cognitive dysfunction in elderly patients: a randomized controlled preliminary trial

    Chinese medical journal

  2. Propofol lowers the risk of postoperative cognitive dysfunction in humans (compared with isoflurane and sevoflurane, on postoperative days 1 and 3) (P<0.001 vs isoflurane at D1 and D3; P=0.012 (D1) and P=0.013 (D3) vs sevoflurane).

    “The incidence of POCD was significantly lower in the propofol group compared to the isoflurane group and the sevoflurane group at D1 and D3”

    Human trialcompared with isoflurane and sevoflurane, on postoperative days 1 and 3

    Effect of propofol, sevoflurane, and isoflurane on postoperative cognitive dysfunction following laparoscopic cholecystectomy in elderly patients: A randomized controlled trial

    Journal of clinical anesthesia

  3. Propofol is linked with a higher risk of postoperative cognitive dysfunction in humans (undergoing surgery with general anesthesia) (aHR 1.16, 95% CI 1.09–1.24).

    “Long-term cognitive dysfunction (aHR 1.16, 95% CI 1.09–1.24) and long-term mortality (aHR 1.23, 95% CI 1.17–1.29) were also increased.”

    Humansundergoing surgery with general anesthesia180–365 daysn = 91,046

    Association of propofol vs. sevoflurane maintenance anesthesia with postoperative delirium, cognitive decline, and mortality in older adults: a global comparative-effectiveness study

    Critical care (London, England)

  4. Propofol lowers the risk of postoperative cognitive dysfunction in humans (noncardiac surgery) (RR 0.37, 95% CI 0.15-0.88).

    “The incidence of POCD on postoperative Days 2-6 after propofol anaesthesia was markedly lower than that after inhalation anaesthesia (risk ratio (RR): 0.37, 95% confidence interval (CI): 0.15-0.88, P = .025)”

    Reviewnoncardiac surgerypostoperative Days 2-6

    Effects of inhalation and propofol anaesthesia on postoperative cognitive dysfunction in elderly noncardiac surgical patients: A systematic review and meta-analysis

    Medicine

More on Propofol

Insulin

downin humans3

3 studies
  1. Insulin lowers the risk of postoperative cognitive dysfunction in humans (4 (13.3%) vs. 12 (38.7%)).

    “The insulin group had a significantly lower POCD rate compared with the control group at postoperative day 7 [4 (13.3%) vs. 12 (38.7%), p = 0.024].”

    Human trialintranasalstarting 2 days before surgery until 1 h before admission to the operating roomn = 61

    Efficacy and safety of intranasal insulin on postoperative cognitive dysfunction in elderly patients after laparoscopic radical resection of colorectal cancer: a double-blind pilot study

    Frontiers in aging neuroscience

  2. Insulin lowers the risk of postoperative cognitive dysfunction in humans after laparoscopic radical resection of colorectal cancer (4(13.3%) vs. 12 (38.7%)).

    “The insulin group had a significantly lower POCD rate compared with the control group at postoperative day 7 [4(13.3%) vs. 12 (38.7%), p = 0.024].”

    Human trialafter laparoscopic radical resection of colorectal cancerpostoperative 7 daysn = 61

    Efficacy and safety of intranasal insulin on postoperative cognitive dysfunction in elderly patients after laparoscopic radical resection of colorectal cancer: a double-blind pilot study

    Frontiers in aging neuroscience

  3. Insulin lowers the risk of postoperative cognitive dysfunction in humans (metabolic syndrome undergoing noncardiac surgery) (20.8% vs 45.1% (P = 0.008)).

    “POCD occurred in the insulin group on the 7th postoperative day in 11 (20.8%) patients, which was fewer than the 23 (45.1%) patients in the placebo group (P = 0.008).”

    Human trialmetabolic syndrome undergoing noncardiac surgery40 IU7 daysn = 116

    Protective effect of intranasal insulin on postoperative cognitive dysfunction in elderly patients with metabolic syndrome undergoing noncardiac surgery: a randomized clinical trial

    Aging clinical and experimental research

  4. Insulin lowers the risk of postoperative cognitive dysfunction in humans (postoperative).

    “reduced incidence of postoperative cognitive dysfunction are demonstrated”

    Reviewpostoperative

    Intranasal insulin in the correction of cognitive impairments with central insulin resistance. A review

    Consilium Medicum

More on Insulin

Sevoflurane

downin humans2upin humans1

3 studies
  1. Sevoflurane lowers the risk of postoperative cognitive dysfunction in humans (high vs low end-tidal concentration) (10.00% vs 24.59%).

    “The incidence of POCD in the high-concentration group was 10.00% (6/60), which was significantly lower than the 24.59% (15/61) observed in the low-concentration group (χ2 = 4.489, P = 0.034).”

    Human trialhigh vs low end-tidal concentrationn = 121

    Association between end-tidal sevoflurane concentration and postoperative cognitive dysfunction and pain sensitivity in elderly patients under general anesthesia

    Frontiers in aging neuroscience

  2. Sevoflurane lowers the risk of postoperative cognitive dysfunction in humans (abdominal surgery) (10.00% vs. 24.59%).

    “The high-concentration group had longer recovery times but a lower incidence of POCD (10.00% vs. 24.59%)”

    Human trialabdominal surgery1.5-2.0 MAC vs 0.8-1.2 MACn = 121

    Association between end-tidal sevoflurane concentration and postoperative cognitive dysfunction and pain sensitivity in elderly patients under general anesthesia

    Frontiers in aging neuroscience

  3. Sevoflurane raises the risk of postoperative cognitive dysfunction in humans (sevoflurane anesthesia for esophageal carcinoma resection).

    “The POCD incidence was higher in elderly patients receiving sevoflurane anesthesia”

    Human trialsevoflurane anesthesia for esophageal carcinoma resection

    Role of dexmedetomidine in reducing the incidence of postoperative cognitive dysfunction caused by sevoflurane inhalation anesthesia in elderly patients with esophageal carcinoma

    Journal of cancer research and therapeutics

  4. Sevoflurane lowers the risk of postoperative cognitive dysfunction in humans (compared with isoflurane, on postoperative day 1 only; not significant on day 3) (P=0.041 at D1).

    “The incidence of POCD was significantly lower in the sevoflurane group compared to the isoflurane group at D1 (P=0.041)”

    Human trialcompared with isoflurane, on postoperative day 1 only; not significant on day 3

    Effect of propofol, sevoflurane, and isoflurane on postoperative cognitive dysfunction following laparoscopic cholecystectomy in elderly patients: A randomized controlled trial

    Journal of clinical anesthesia

More on Sevoflurane

Esketamine

downin humans3

3 studies
  1. Esketamine lowers the risk of postoperative cognitive dysfunction in humans (undergoing laparoscopic radical prostatectomy).

    “MMSE scores at 1 and 7 days post surgery were higher, and POCD incidence was lower (P < 0.05).”

    Human trialundergoing laparoscopic radical prostatectomyn = 186

    Efficacy and Safety of Intravenous Esketamine in Elderly Patients Undergoing Laparoscopic Radical Prostatectomy

    Journal of visualized experiments : JoVE

  2. Esketamine lowers the risk of postoperative cognitive dysfunction in humans (11.4% versus 31.8% on day 1, 0.0% versus 13.6% on day 3).

    “Notably, the incidence of POCD on days 1 (11.4% versus 31.8%, p < 0.05) and 3 (0.0% versus 13.6%, p < 0.05, Table ) after the surgery were significantly lower in the esketamine group than in the control group.”

    Human trialinfused until 30 min before the end of the surgeryn = 102

    Effects of Esketamine on Postoperative Cognitive Function in Elderly Patients Undergoing Pulmonary Lobectomy: A Randomised, Single-Blind Controlled Clinical Trial

    Actas espanolas de psiquiatria

  3. Esketamine lowers the risk of postoperative cognitive dysfunction in humans (pulmonary lobectomy).

    “the esketamine group exhibited a significantly lower incidence of POCD on days 1 and 3 postoperatively than the control group”

    Human trialpulmonary lobectomy0.3 mg/kg/h

    Effects of Esketamine on Postoperative Cognitive Function in Elderly Patients Undergoing Pulmonary Lobectomy: A Randomised, Single-Blind Controlled Clinical Trial

    Actas espanolas de psiquiatria

  4. Esketamine is linked with a lower risk of postoperative cognitive dysfunction in humans (elective thoracic surgery) (18.7% vs. 36.0%, P < 0.05).

    “reduced POCD at 1 month (18.7% vs. 36.0%, P < 0.05) and 6 months (10.7% vs. 21.3%, P < 0.05)”

    Humanselective thoracic surgery1 month post-surgeryn = 140

    The influence of low-dose s-ketamine on postoperative delirium and cognitive function in older adults undergoing thoracic surgery

    Journal of cardiothoracic surgery

More on Esketamine

Frailty

upin humans2upin rats1OR 5.38

3 studies
  1. Frailty is linked with a higher risk of postoperative cognitive dysfunction in humans (undergoing elective surgery).

    “Factors significantly associated with POCD (p < 0.05) included age, ASA III classification, female gender, major surgeries, frailty, preoperative depression, type of anesthesia, intraoperative hypotension and blood loss”

    Humansundergoing elective surgery

    Incidence and predictors of postoperative cognitive dysfunction among elderly elective surgical patients at selected governmental hospitals in Southern Ethiopia, 2023 GC: a multicenter prospective single arm cohort study

    BMC geriatrics

  2. Frailty is linked with a higher risk of postoperative cognitive dysfunction in humans (undergoing non-cardiac surgery under general anaesthesia) (OR 5.380, 95% CI 1.718–16.685).

    “5.8 times higher risk of POCD (OR: 5.380, 95% CI: 1.718, 16.685, P = 0.004) compared to non-frail counterparts.”

    Humansundergoing non-cardiac surgery under general anaesthesian = 117

    Association between preoperative frailty and postoperative delirium and cognitive dysfunction in elderly patients undergoing surgery under general anaesthesia: A prospective observational study

    Indian journal of anaesthesia

  3. Frailty is associated with postoperative cognitive dysfunction in rats after general anaesthesia; frailty induced by hind limb immobilisation (Y-maze alternation ratio 65% ± 37% vs 29% ± 28%, p = 0.01).

    “Frailty was significantly associated with POCD.”

    Animalsafter general anaesthesia; frailty induced by hind limb immobilisationtwo days after general anaesthesiamalesn = 20

    Frailty increases vulnerability to postoperative cognitive dysfunction following general anesthesia in aged rats

    International journal of medical sciences

Hypertension

upin humans3OR 4.153

3 studies
  1. Hypertension is linked with a higher risk of postoperative cognitive dysfunction in humans (elderly patients undergoing oromaxillofacial malignancy surgery) (OR = 4.153, 95% CI: 1.355-12.732).

    “hypertension (OR = 4.153, 95% CI: 1.355-12.732), sleep disorders (OR = 1.272, 95% CI: 1.001-1.617), prolonged anesthesia time (OR = 1.009, 95% CI: 1.001-1.018)”

    Humanselderly patients undergoing oromaxillofacial malignancy surgeryn = 112

    A WeChat mini-program-based perioperative cognitive management tool (WACDAM): development and clinical evaluation in elderly patients undergoing oromaxillofacial malignancy surgery-a mixed-methods study

    Perioperative medicine (London, England)

  2. Hypertension is linked with a higher risk of postoperative cognitive dysfunction in humans (undergoing surgery for oral malignancies) (OR 4.153, 95% CI 1.335-12.732).

    “hypertension (OR = 4.153, 95% CI 1.335-12.732, P < 0.05)”

    Humansundergoing surgery for oral malignanciesn = 112

    Risk factors for postoperative cognitive dysfunction in elderly patients undergoing surgery for oral malignancies

    Perioperative medicine (London, England)

  3. Hypertension is linked with a higher risk of postoperative cognitive dysfunction in humans (undergoing surgery for oral malignancies) (OR 4.153, 95% CI 1.335-12.732).

    “hypertension (OR=4.153, 95%CI1.335-12.732, P<0.05)”

    Humansundergoing surgery for oral malignanciesn = 112

    Analysis of risk factors for postoperative cognitive dysfunction in older patients undergoing surgery for oral malignancies

    Research SquarePreprint

More on Hypertension

Age

upin humans3OR 1.269

3 studies
  1. Age is linked with a higher risk of postoperative cognitive dysfunction in humans (elderly patients undergoing oromaxillofacial malignancy surgery) (OR = 1.269, 95% CI: 1.056-1.525).

    “Multivariable logistic regression identified older age (OR = 1.269, 95% CI: 1.056-1.525), lower education level (OR = 0.792, 95% CI: 0.644-0.974), hypertension (OR = 4.153, 95% CI: 1.355-12.732)”

    Humanselderly patients undergoing oromaxillofacial malignancy surgeryn = 112

    A WeChat mini-program-based perioperative cognitive management tool (WACDAM): development and clinical evaluation in elderly patients undergoing oromaxillofacial malignancy surgery-a mixed-methods study

    Perioperative medicine (London, England)

  2. Age is associated with postoperative cognitive dysfunction in humans (cardiac surgery with CPB) (63 [58–68] vs. 59 [52–65] years, p = 0.026).

    “Patients who developed POCD were significantly older than those without POCD (median (interquartile range [IQR]): 63 [58–68] vs. 59 [52–65] years; p = 0.026).”

    Humanscardiac surgery with CPBn = 74

    Evaluation of Intraoperative Cerebral Desaturation and Risk Factors Associated With Cognitive Dysfunction After Cardiac Surgery: A Prospective Observational Study

    The Heart Surgery Forum

  3. Age is linked with a higher risk of postoperative cognitive dysfunction in humans (undergoing surgery for oral malignancies) (OR 1.269, 95% CI 1.056-1.525).

    “Multiple factor logistic regression analysis revealed that age (OR=1.269, 95%CI 1.056-1.525, P<0.05)”

    Humansundergoing surgery for oral malignanciesn = 112

    Analysis of risk factors for postoperative cognitive dysfunction in older patients undergoing surgery for oral malignancies

    Research SquarePreprint

Advanced age

upin humans3

3 studies
  1. Advanced age is linked with a higher risk of postoperative cognitive dysfunction in humans (elective neurosurgical procedures).

    “Advanced age (≥65 years), low education level, intraoperative hypotension, and postoperative delirium were significant predictors of POCD”

    Humanselective neurosurgical proceduresn = 150

    Impact of Anesthetic Techniques on Postoperative Cognitive Dysfunction Following Neurosurgery

    Annals of International medical and Dental Research

  2. Advanced age is associated with postoperative cognitive dysfunction in humans (postoperative day 3) (P = 0.044).

    “advanced age and elevated creatinine (day 3, P value = 0.044, P value = 0.008), and hypoalbuminemia (day 3, P value = 0.042; day 7, P value = 0.015) were independently associated with early POCD.”

    Humanspostoperative day 3n = 125

    Impact of ambient temperature on postoperative cognitive dysfunction in elderly patients surgery: A seasonal comparison in tropical regions

    World journal of psychiatry

  3. advanced age raises the risk of postoperative cognitive dysfunction in humans.

    “Advanced age is considered as an independent risk factor of POCD.”

    Review

    Postoperative cognitive dysfunction in the aged: the collision of neuroinflammaging with perioperative neuroinflammation

    Inflammopharmacology

Ketamine

downin humans2upin humans1

3 studies
  1. Ketamine lowers the risk of postoperative cognitive dysfunction in humans.

    “Additionally, there was a rise in the number of patients who developed POCD in the control group when compared to ketamine and dexmedetomidine groups (P < 0.0001); however, the ketamine and dexmedetomidine groups did not vary from one another (P = 0.747)..”

    Human trialstarted 10 min before the start of surgery and continued throughout the duration of surgeryn = 90

    Effects of ketamine or dexmedetomidine on postoperative cognitive dysfunction after cataract surgery: A randomized controlled trial

    Indian journal of anaesthesia

  2. Ketamine lowers the risk of postoperative cognitive dysfunction in humans (geriatric anesthesia).

    “low-dose ketamine (0.3-0.5 mg/kg) is neuroprotective and decreases the rate of cognitive dysfunction in certain patients”

    Reviewgeriatric anesthesia0.3-0.5 mg/kg

    The impact of ketamine on cognitive outcomes in geriatric anesthesia: a comprehensive review

    Frontiers in psychiatry

  3. Ketamine raises the risk of postoperative cognitive dysfunction in humans (compared with remimazolam and dexmedetomidine).

    “ketamine was likely associated with an increased risk of POCD, similar to propofol, when compared to remimazolam and dexmedetomidine”

    Reviewcompared with remimazolam and dexmedetomidine

    Impact of Ketamine and Propofol on Cognitive Function in Elderly Patients: A Systematic Review

    Cureus

More on Ketamine

Probiotics

downin humans2RR 0.47

2 studies
  1. Probiotics lower the risk of postoperative cognitive dysfunction in humans (6.7% vs. 17.2%).

    “POCD occurred in 6 out of 90 patients in the probiotics group and 16 out of 93 patients in the control group, and the incidence of POCD in the probiotic group was significantly lower than that in the control group (6.7% vs. 17.2%, P = 0.028).”

    Human trialfrom 1 day before to 5 days after surgery

    Effect of perioperative probiotic intervention on postoperative cognitive dysfunction in elderly patients: a randomized double- blinded and placebo-controlled trial

    Journal of translational medicine

  2. Probiotics lower the risk of postoperative cognitive dysfunction in humans (elective lower-extremity orthopedic surgery) (6.7% vs. 17.2%, P = 0.028).

    “The incidence of POCD in the probiotic group was significantly lower than in the control group (6 of 90 patients [6.7%] vs. 16 of 93 patients [17.2%], P = 0.028).”

    Human trialelective lower-extremity orthopedic surgeryorally, 2 times/day210 mgx4/dosefrom 1 day before surgery to 5 days after surgery

    Effect of perioperative probiotic intervention on postoperative cognitive dysfunction in elderly patients: a randomized double- blinded and placebo-controlled trial

    Journal of translational medicine

  3. Probiotics lower the risk of postoperative cognitive dysfunction in humans (RR, 0.47 [95% CI, 0.27 to 0.81]).

    “Postoperative cognitive dysfunction occurred in 12 (26.7%) of 45 patients in the probiotic group and 29 (56.9%) of 51 patients in the placebo group (RR, 0.47 [95% CI, 0.27 to 0.81]; P = 0.003, ).”

    Human trialn = 96

    Perioperative probiotics attenuates postoperative cognitive dysfunction in elderly patients undergoing hip or knee arthroplasty: A randomized, double-blind, and placebo-controlled trial

    Frontiers in aging neuroscience

  4. Probiotics lower the risk of postoperative cognitive dysfunction in humans (undergoing elective hip or knee arthroplasty) (RR 0.47 (95% CI 0.27 to 0.81), P = 0.003).

    “POCD occurred in 12 (26.7%) of 45 patients in the probiotic group and 29 (56.9%) of 51 patients in the placebo group (relative risk [RR], 0.47 [95% confidence interval [CI], 0.27 to 0.81]; P = 0.003).”

    Human trialundergoing elective hip or knee arthroplastyfour capsules, twice/dayfrom hospital admission until dischargen = 96

    Perioperative probiotics attenuates postoperative cognitive dysfunction in elderly patients undergoing hip or knee arthroplasty: A randomized, double-blind, and placebo-controlled trial

    Frontiers in aging neuroscience

More on Probiotics

Stellate ganglion block

downin humans2

2 studies
  1. Stellate ganglion block lowers the risk of postoperative cognitive dysfunction in humans.

    “As determined by the MMSE and MoCA scores, the incidence of POCD on T8 was significantly lower in the SG group, when compared to the control group (p < 0.05, ).”

    Human trialtwo hours or greatern = 104

    Improved early postoperative cognition in elderly gastrointestinal patients: a randomized controlled trial on the role of ultrasound-guided stellate ganglion block

    Frontiers in aging neuroscience

  2. Stellate ganglion block lowers the risk of postoperative cognitive dysfunction in humans (postoperative day one after laparoscopic gastrointestinal surgery) (p < 0.05).

    “The SGB group had a significantly lower incidence of POCD on postoperative day one (p < 0.05).”

    Human trialpostoperative day one after laparoscopic gastrointestinal surgeryn = 98

    Improved early postoperative cognition in elderly gastrointestinal patients: a randomized controlled trial on the role of ultrasound-guided stellate ganglion block

    Frontiers in aging neuroscience

  3. Stellate ganglion block lowers the risk of postoperative cognitive dysfunction in humans.

    “Compared with Group C, MMSE scores were significantly higher and the incidence of POCD was significantly lower at T9 and T10 in Group S (P < 0.05) (Table 5).”

    Human trialn = 40

    Effects of stellate ganglion block on postoperative cognitive dysfunction in elderly patients undergoing radical resection of gastrointestinal malignant tumor

    Research SquarePreprint

  4. Stellate ganglion block lowers the risk of postoperative cognitive dysfunction in humans (elderly patients undergoing radical resection of gastrointestinal malignant tumor) (P< 0.05).

    “lower incidence of POCD (P< 0.05).”

    Human trialelderly patients undergoing radical resection of gastrointestinal malignant tumorn = 40

    Effects of stellate ganglion block on postoperative cognitive dysfunction in elderly patients undergoing radical resection of gastrointestinal malignant tumor

    Research SquarePreprint

More on Stellate ganglion block

Neostigmine

downin humans2upin humans1OR 0.31–1.74

2 studies
  1. Neostigmine lowers the risk of postoperative cognitive dysfunction in humans (-22% (95% CI, -37 to -7)).

    “Patients receiving neostigmine had a significantly reduced incidence of POCD compared to patients who were treated with placebo on the first day after surgery (-22%, 95% confidence interval [CI], -37 to -7)”

    Human trial0.04 mg/kgn = 118

    Influence of Neostigmine on Early Postoperative Cognitive Dysfunction in Older Adult Patients Undergoing Noncardiac Surgery: A Double-Blind, Placebo-Controlled, Randomized Controlled Trial

    Anesthesia and analgesia

  2. Neostigmine lowers the risk of postoperative cognitive dysfunction in humans (postoperative general anesthesia with neuromuscular blockade) (OR 0.31, 95% CI 0.15-0.63).

    “administration of a higher dose (≥0.04 mg/kg) was associated with reduced POCD incidence compared to a lower dose (<0.04 mg/kg) (OR 0.31, 95% CI 0.15-0.63, p = 0.001)”

    Reviewpostoperative general anesthesia with neuromuscular blockade≥0.04 mg/kg vs <0.04 mg/kg

    Effect of Reversal Agents on Postoperative Cognitive Disorders Following General Anesthesia in the Elderly Population: A Systematic Review and Meta-Analysis

    Diagnostics (Basel, Switzerland)

  3. Neostigmine raises the risk of postoperative cognitive dysfunction in humans (postoperative general anesthesia with neuromuscular blockade) (OR 1.74, 95% CI 1.00-3.02).

    “neostigmine was associated with a higher risk of POCD than sugammadex (OR 1.74, 95% CI 1.00-3.02, p = 0.05)”

    Reviewpostoperative general anesthesia with neuromuscular blockaden = 795

    Effect of Reversal Agents on Postoperative Cognitive Disorders Following General Anesthesia in the Elderly Population: A Systematic Review and Meta-Analysis

    Diagnostics (Basel, Switzerland)

More on Neostigmine

Remimazolam

downin humans2

2 studies
  1. Remimazolam lowers the risk of postoperative cognitive dysfunction in humans.

    “The incidence of POCD at T8 and T9 was significantly lower in Group R than Group M (P = 0.031 and P = 0.017, respectively).”

    Human trialn = 70

    Effects of Remimazolam on Intraoperative Frontal Alpha Band Power Spectrum Density and Postoperative Cognitive Function in Older Adults Undergoing Lower Extremity Fractures Surgeries: A Randomized Controlled Trial

    Clinical interventions in aging

  2. Remimazolam lowers the risk of postoperative cognitive dysfunction in humans (lower extremity fracture surgery under general anesthesia) (P = 0.031 and P = 0.017).

    “significantly lower incidence of postoperative cognitive dysfunction at T8 and T9 (P = 0.031 and P = 0.017, respectively)”

    Human triallower extremity fracture surgery under general anesthesia0.1 mg/kg bolus followed by 0.1 mg·kg−1·h−1

    Effects of Remimazolam on Intraoperative Frontal Alpha Band Power Spectrum Density and Postoperative Cognitive Function in Older Adults Undergoing Lower Extremity Fractures Surgeries: A Randomized Controlled Trial

    Clinical interventions in aging

  3. Remimazolam lowers the risk of postoperative cognitive dysfunction in humans.

    “At 3 days postoperative (T6) and 7 days postoperative (T7), there was no statistically significant difference (p > 0.05) in the incidence of POCD between groups R and D, even though both were lower than the incidence of POCD in group C, which was statistically significant (p < 0.05).”

    Human trial

    Comparison of the effects of remimazolam and dexmedetomidine on early postoperative cognitive function in elderly patients with gastric cancer

    Frontiers in aging neuroscience

More on Remimazolam

All 158

Trial sponsors

Funding

19 grants since 2017

National Institute on Aging$6.1MJapan Society for the Promotion of Science¥55.8MNational Cancer Institute$727K

Latest

Dec 2025: 16Jan 2026: 12Feb 2026: 20Mar 2026: 14Apr 2026: 15May 2026: 10Jun 2026: 7Jul 2026: 11Aug 2026: 8Sep 2026: 8Oct 2026: 12Nov 2026: 4137 papers in 12 months

See all 596 papers on postoperative cognitive dysfunction